| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $370.8M | +31.8% |
| Cost of Revenue | $70.4M | +45.6% |
| Gross Profit | $300.4M | +28.9% |
| R&D Expense | $134.9M | +41.0% |
| SG&A Expense | $99.2M | +28.2% |
| Operating Income | -$129.4M | -27.2% |
| Interest Expense | $5.4M | +0.6% |
| Pre-tax Income | -$130.1M | -21.6% |
| Income Tax | -$839K |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $274.0M | -21.7% |
| Short-term Investments | $202.9M | +4.8% |
| Accounts Receivable | $91.3M | +21.3% |
| Current Assets | $600.3M | -6.9% |
| Total Assets | $817.9M | +1.4% |
| Current Liabilities | $271.1M | +19.4% |
| Long-term Debt | $296.5M | -1.2% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.0M | +382.0% |
| Capital Expenditures | $4.6M | +34.1% |
| Investing Cash Flow | -$86.2M | -595.9% |
| Financing Cash Flow | -$6.4M | -771.3% |
| Free Cash Flow | $12.3M | +230.2% |
| -256.8% |
| Net Income | -$128.4M | -19.5% |
| EPS (Basic) | -$1.45 | -14.2% |
| EPS (Diluted) | -$1.45 | -14.2% |
| Total Liabilities |
| $575.8M |
| +6.7% |
| Stockholders' Equity | $241.0M | -9.7% |